The ARIES-HM3 trial analysis found that in advanced heart failure patients with traditional indications for antiplatelet ...

This country research report on Vietnam Atherosclerosis Drugs Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.

JJ is a 75-year-old man who presents to the office after his wife made an appointment for him this morning for evaluation of ...

The risk for recurrent cardiovascular events is high among patients with r-axSpA and a history of these events, though TNF inhibitor therapy may offer protective benefits.

I am Greek and have thalassemia minor. In general, my red blood cells are much smaller than typical ones, and my iron content ...

In the medical world, having heart disease puts you in a high-risk category that demands aggressive preventive care. Now, researchers have discovered something unexpected: surviving a severe case of ...

CLPH-291 is under clinical development by Cellphire and currently in Phase II for Wiskott-Aldrich Syndrome. According to GlobalData, Phase II drugs for Wiskott-Aldrich Syndrome have a 100% phase ...

KL College of Pharmacy at KL Deemed to be University, is making significant strides in neuropharmacology through several ...

The following is a summary of “Antiplatelet therapy is not associated with increased risk of complications after lumbar ...

After about 10 months of being on Ozempic and working my way up to a 1-mg dose, I lost 40 pounds effortlessly. Sugar cravings ...

Undersized donor hearts were indeed associated with more post-transplantation mortality -- but only among complex transplant ...